Tigecycline: a review of the literature
Tigecycline is a new first-in-class glycylcycline antimicrobial agent with expanded broad-spectrum activity. It was developed to overcome the two key resistance mechanisms, efflux pumps and ribosomal protection, that limit the use of tetracycline. The spectrum of activity extends to clinically relev...
Main Authors: | Mario Venditti, Maria Elena Pompeo, Flavia Fabi |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2006-01-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/256 |
Similar Items
-
Molecular mechanisms of tigecycline-resistance among Enterobacterales
by: Lukasz Korczak, et al.
Published: (2024-04-01) -
In vitro antimicrobial activity of tigecycline against Gram negative and Gram positive pathogens collected in Northen Italy (T.E.S.T. program 2010)
by: Erika Coppo, et al.
Published: (2011-03-01) -
Progression of Fibrinogen Decrease during High Dose Tigecycline Therapy in Critically Ill Patients: A Retrospective Analysis
by: Benedikt Treml, et al.
Published: (2021-10-01) -
Resistance mechanisms of tigecycline in Acinetobacter baumannii
by: Chunli Sun, et al.
Published: (2023-05-01) -
Emergence of microbial infections in some hospitals of Cairo, Egypt: studying their corresponding antimicrobial resistance profiles
by: Asmaa K. Helmy, et al.
Published: (2023-06-01)